CD4 and infection: Accumulated evidence from numerous longitudinal COVID-19 patient cohort studies have shown that a coordinated adaptive immune response, characterized by the rapid expansion of both SARS-CoV-2-specific CD4 and CD8 T cells and virus-specific NAbs, within seven days of infection, is correlated with protection from severe disease [41,55,70,71,72].